Meprelon solution

Product description

The active substance of Meprelon belongs to the family of modified adrenocortical hormones (glucocorticoids). Meprelon contains a high dose of the active substance in a form sparingly soluble in water. Therefore, Meprelon is administered directly into the bloodstream in acute, life-threatening conditions that require glucocorticoid therapy. Meprelon is used in acute, life-threatening conditions such as:

  • shock associated with severe systemic allergic reaction (anaphylactic shock)
  • after previous administration of noradrenaline (a drug acting on the circulatory system),
  • cerebral oedema (only in case of symptoms of increased intracranial pressure demonstrated by computed tomography) caused by a brain tumour, neurosurgical procedures, brain abscess, bacterial meningitis;
  • persisting shock lung (Adult Respiratory Distress Syndrome – ARDS) after the acute phase, severe acute asthma attack;
  • severe systemic bacterial infection with adrenocortical insufficiency (Waterhouse–Friderichsen syndrome),
  • risk of organ rejection after kidney transplantation;
  • accumulation of water in lung tissues following inhalation of toxic gases (toxic pulmonary oedema).